Lisa D Earnhardt insider trades: Abbott Laboratories (ABT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lisa reports to the SEC
Open-market buys and sales
47 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | ABT | ↓ Sell | 91,367 | $133.83 | $12.2M | Direct | Mar 7, 2025 (0d) |
| May 7, 2024 | ABT | ↓ Sell | 22,852 | $106.25 | $2.4M | Direct | May 8, 2024 (1d) |
| Mar 1, 2024 | ABT | ↓ Sell | 694 | $118.50 | $82K | Direct | Mar 4, 2024 (3d) |
| Mar 1, 2023 | ABT | ↓ Sell | 943 | $100.70 | $95K | Direct | Mar 2, 2023 (1d) |
| Mar 1, 2022 | ABT | ↓ Sell | 943 | $118.15 | $111K | Direct | Mar 2, 2022 (1d) |
| Mar 1, 2021 | ABT | ↓ Sell | 943 | $120.61 | $114K | Direct | Mar 2, 2021 (1d) |
| Jun 10, 2020 | ABT | ↓ Sell | 872 | $90.84 | $79K | Direct | Jun 12, 2020 (2d) |
| May 15, 2019 | XENT | ↓ Sell | 9,500 | $25.59 | $243K | Direct | May 17, 2019 (2d) |
| Apr 15, 2019 | XENT | ↓ Sell | 29,588 | $28.43 | $841K | Direct | Apr 17, 2019 (2d) |
| Dec 17, 2018 | XENT | ↓ Sell | 20,000 | $29.73 | $595K | Direct | Dec 19, 2018 (2d) |
| Nov 15, 2018 | XENT | ↓ Sell | 20,000 | $30.01 | $600K | Direct | Nov 19, 2018 (4d) |
| Oct 15, 2018 | XENT | ↓ Sell | 20,000 | $29.63 | $593K | Direct | Oct 17, 2018 (2d) |
| Sep 17, 2018 | XENT | ↓ Sell | 20,000 | $29.14 | $583K | Direct | Sep 19, 2018 (2d) |
| Aug 15, 2018 | XENT | ↓ Sell | 20,000 | $26.51 | $530K | Direct | Aug 17, 2018 (2d) |
| Jul 16, 2018 | XENT | ↓ Sell | 20,000 | $33.08 | $662K | Direct | Jul 18, 2018 (2d) |
| Jun 15, 2018 | XENT | ↓ Sell | 20,000 | $36.79 | $736K | Direct | Jun 19, 2018 (4d) |
| May 15, 2018 | XENT | ↓ Sell | 15,000 | $39.22 | $588K | Direct | May 17, 2018 (2d) |
| Apr 16, 2018 | XENT | ↓ Sell | 15,000 | $39.59 | $594K | Direct | Apr 17, 2018 (1d) |
| Mar 15, 2018 | XENT | ↓ Sell | 15,000 | $38.32 | $575K | Direct | Mar 16, 2018 (1d) |
| Feb 15, 2018 | XENT | ↓ Sell | 15,000 | $36.40 | $546K | Direct | Feb 16, 2018 (1d) |
| Jan 18, 2018 | XENT | ↓ Sell | 11,166 | $33.47 | $374K | Direct | Jan 19, 2018 (1d) |
| Dec 15, 2017 | XENT | ↓ Sell | 10,685 | $31.87 | $341K | Direct | Dec 18, 2017 (3d) |
| Nov 15, 2017 | XENT | ↓ Sell | 20,000 | $27.88 | $558K | Direct | Nov 17, 2017 (2d) |
| Oct 16, 2017 | XENT | ↓ Sell | 20,000 | $28.37 | $567K | Direct | Oct 17, 2017 (1d) |
| Sep 15, 2017 | XENT | ↓ Sell | 20,000 | $30.19 | $604K | Direct | Sep 19, 2017 (4d) |
| Aug 15, 2017 | XENT | ↓ Sell | 20,000 | $30.79 | $616K | Direct | Aug 17, 2017 (2d) |
| Jul 17, 2017 | XENT | ↓ Sell | 20,000 | $29.03 | $581K | Direct | Jul 18, 2017 (1d) |
| Jun 15, 2017 | XENT | ↓ Sell | 20,000 | $26.10 | $522K | Direct | Jun 19, 2017 (4d) |
| May 15, 2017 | XENT | ↓ Sell | 20,000 | $22.98 | $460K | Direct | May 16, 2017 (1d) |
| Apr 17, 2017 | XENT | ↓ Sell | 20,000 | $16.06 | $321K | Direct | Apr 18, 2017 (1d) |
| Mar 15, 2017 | XENT | ↓ Sell | 20,000 | $15.02 | $300K | Direct | Mar 16, 2017 (1d) |
| Feb 15, 2017 | XENT | ↓ Sell | 20,000 | $13.01 | $260K | Direct | Feb 17, 2017 (2d) |
| Oct 17, 2016 | XENT | ↓ Sell | 400 | $18.00 | $7K | Direct | Oct 19, 2016 (2d) |
| Apr 18, 2016 | XENT | ↓ Sell | 28,500 | $18.69 | $533K | Direct | Apr 19, 2016 (1d) |
| Mar 15, 2016 | XENT | ↓ Sell | 9,000 | $18.01 | $162K | Direct | Mar 16, 2016 (1d) |
| Jan 15, 2016 | XENT | ↓ Sell | 12,500 | $19.26 | $241K | Direct | Jan 20, 2016 (5d) |
| Dec 15, 2015 | XENT | ↓ Sell | 6,820 | $19.85 | $135K | Direct | Dec 16, 2015 (1d) |
| Nov 16, 2015 | XENT | ↓ Sell | 6,818 | $18.00 | $123K | Direct | Nov 17, 2015 (1d) |
| Oct 15, 2015 | XENT | ↓ Sell | 6,818 | $18.72 | $128K | Direct | Oct 16, 2015 (1d) |
| Sep 15, 2015 | XENT | ↓ Sell | 6,818 | $25.99 | $177K | Direct | Sep 16, 2015 (1d) |
| Aug 17, 2015 | XENT | ↓ Sell | 6,818 | $28.51 | $194K | Direct | Aug 19, 2015 (2d) |
| Jul 15, 2015 | XENT | ↓ Sell | 19,318 | $29.62 | $572K | Direct | Jul 16, 2015 (1d) |
| Jun 15, 2015 | XENT | ↓ Sell | 19,318 | $29.30 | $566K | Direct | Jun 16, 2015 (1d) |
| May 15, 2015 | XENT | ↓ Sell | 19,318 | $23.69 | $458K | Direct | May 19, 2015 (4d) |
| Apr 15, 2015 | XENT | ↓ Sell | 19,318 | $25.96 | $502K | Direct | Apr 17, 2015 (2d) |
| Mar 16, 2015 | XENT | ↓ Sell | 19,318 | $23.56 | $455K | Direct | Mar 18, 2015 (2d) |
| Feb 17, 2015 | XENT | ↓ Sell | 19,318 | $22.69 | $438K | Direct | Feb 19, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ABT insiders
Open-market trades in the last 12 months
About Lisa D Earnhardt's insider trades
Lisa D Earnhardt is EVP and Group President at Abbott Laboratories (ABT). Since Feb 17, 2015, Lisa has reported no open-market purchases and 47 sales worth $33.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (29 filings), grants and awards (20 filings), shares withheld for taxes (10 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.